Deadly fungal infection reported in US
- Author: Joanne Flowers Mar 14, 2017,
Mar 14, 2017, 17:51
More than 30 patients have been diagnosed with Candida auris, a fungal infection typically found in hospitals or similar places. The fungal infection can survive at least a month on a person's skin while traces of it have been found on chairs, bed rails, and hospital equipment weeks after the initial exposure.
The fungus is a kind of yeast known as Candida auris has been reported overseas since 2009, according to The Washington Post.
Candida auris has been resistant to the three types of major antifungal drugs because it is an invasive bloodstream infection that can affect the blood, heart, and other parts of the body that are more unsafe.
"This drug is especially promising because of its broad anti-Candida activity, including activity against drug-susceptible and resistant strains", said Dr. Ghannoum. Since then, the fungus has been reported along with this country including, Colombia, India, Israel, Kenya, Pakistan, South Korea, Venezuela, and the United Kingdom.
In the United States, the biggest number of deadly fungal infections has been reported in NY. Out of 60 cases in the United States, 28 have been recorded in NY. Now, the CDC is engaged in tracking all the infections, updating the number of patients every few weeks. In the United States, most of the infections have been reported in NY, with at least 28 cases to date. It is also a highly fatal disease, as it has been known to kill up to 60 percent of sufferers, many of whom had "other serious underlying illnesses" aside from the fungal infection. Tom Chiller speaking with Perfscience said that after alerting the public, information started to be reported to the the CDC, which helped them better understand how it spreads and how it's acting. This drug was previously proven to be effective against other strains of Candida, such as C. albicans and C. tropicalis, that are linked with catheter-related infections. Higher doses of antifungal medication may be necessary to treat the fungal infection.
Candida Auris is a fungus species that grows as yeast. It can cause severe bloodstream infections and is multidrug resistant. In June 2016, the CDC delivered a warning to all physicians asking them to look for these infections which, apparently, are hard to be determined by standard laboratory methods. Misidentification may lead to inappropriate treatment. For this reason, rapid identification of C. auris in a hospitalized patient is particularly important so that hospitals can take special precautions to stop its spread.